Market Closed -
Other stock markets
|
After market 01:04:23 pm | |||
41.85 USD | +1.47% | 41.76 | -0.23% |
03:31pm | Bristol-Myers Squibb Says Opdivo Plus Yervoy Therapy Improves Survival of Liver Cancer Patients | MT |
02:38pm | Bristol Myers: positive results in liver cancer | CF |
Financials (USD)
Sales 2024 * | 46.09B | Sales 2025 * | 46.06B | Capitalization | 84.67B |
---|---|---|---|---|---|
Net income 2024 * | -5.41B | Net income 2025 * | 10.22B | EV / Sales 2024 * | 2.68 x |
Net Debt 2024 * | 39.03B | Net Debt 2025 * | 31.68B | EV / Sales 2025 * | 2.53 x |
P/E ratio 2024 * |
-15.9
x | P/E ratio 2025 * |
7.9
x | Employees | 34,100 |
Yield 2024 * |
5.76% | Yield 2025 * |
6.05% | Free-Float | 69.27% |
Latest transcript on Bristol-Myers Squibb Company
1 day | +1.22% | ||
1 week | +3.06% | ||
Current month | +1.96% | ||
1 month | -5.08% | ||
3 months | -18.10% | ||
6 months | -16.53% | ||
Current year | -18.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 15-01-31 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 19-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 16-03-31 |
Derica Rice
BRD | Director/Board Member | 59 | 20-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 41.85 | +1.47% | 778 |
24-06-03 | 41.98 | +2.28% | 17,963 |
24-05-31 | 41.05 | +1.31% | 50,319 |
24-05-30 | 40.52 | +0.25% | 15,286 |
24-05-29 | 40.42 | -0.46% | 29,888 |
Delayed Quote London S.E., June 04, 2024 at 11:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.13% | 748B | |
+34.11% | 598B | |
-6.55% | 356B | |
+18.12% | 325B | |
+4.30% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.24% | 166B |
- Stock Market
- Equities
- BMY Stock
- 0R1F Stock